background
banner

DIANEAL PD4 GLUCOSE 1.36% w/v Price

Active Substance: Dialysis Fluid - Anhydrous Glucose, Sodium chloride, Sodium lactate, Calcium chloride, Magnesium chloride,.

114
UAD , based on 7541 reviews.
View Drug details

Overview

Welcome to Dwaey, specifically on DIANEAL PD4 GLUCOSE 1.36% w/v page.
This medicine contains an important and useful components, as it consists of
Dialysis Fluid - Anhydrous Glucose, Sodium chloride, Sodium lactate, Calcium chloride, Magnesium chloride,is available in the market in concentration

Name

Prednisolone Acetate + Neomycin Sulphate E&E prep

Precaution

Before using **Prednisolone Acetate + Neomycin Sulphate E&E Prep**, it is critical to consult a healthcare provider to ensure it is appropriate for the patient's condition. The following precautions should be considered: - **Eye Infections**: This medication should **not** be used in cases of **viral**, **fungal**, or **mycobacterial eye infections**, as **prednisolone acetate** (a corticosteroid) may worsen these infections. The use of neomycin for such infections can also be ineffective. - **Glaucoma**: **Prednisolone acetate** can increase **intraocular pressure**, leading to **glaucoma**. This medication should be used cautiously in patients with a history of **glaucoma** or those at risk of developing it. Regular eye pressure monitoring is essential. - **Cataracts**: Prolonged use of corticosteroids such as **prednisolone acetate** can contribute to the development of **cataracts**. Extended use should be avoided unless under medical supervision. - **Hypersensitivity to Neomycin**: Patients with a known **allergy to neomycin** or **other aminoglycosides** should avoid this medication, as it may cause severe allergic reactions such as itching, redness, or swelling in the eyes. - **Pregnancy and Lactation**: The safety of this combination in **pregnancy** and **breastfeeding** is not well-established. It should be used during pregnancy only if the benefits outweigh the risks, and breastfeeding mothers should avoid contact with the treated eye to prevent passing the drug to the infant.

Indication

**Prednisolone Acetate + Neomycin Sulphate E&E Prep** is used to treat eye conditions that involve both **inflammation** and **bacterial infection**. Common indications include: - **Ocular Inflammation**: This combination is effective in treating inflammation resulting from conditions like **conjunctivitis**, **iritis**, or **uveitis**, where an **anti-inflammatory** effect is necessary. - **Bacterial Conjunctivitis**: The antibiotic **neomycin** helps treat **bacterial eye infections** such as **conjunctivitis** (pink eye) caused by susceptible bacteria. - **Postoperative Inflammation**: Following eye surgeries (such as **cataract surgery** or **corneal transplant**), this combination helps reduce inflammation and prevent infection. - **Blepharitis**: Used for the treatment of **blepharitis**, an inflammation of the eyelid, particularly if bacterial infection is involved. - **Corneal Ulcers**: In some cases, this medication may be prescribed for **corneal ulcers** if the inflammation is accompanied by a bacterial infection.

Contra indication

**Prednisolone Acetate + Neomycin Sulphate E&E Prep** should be avoided in certain situations to ensure patient safety: - **Active Viral, Fungal, or Mycobacterial Infections**: The combination should **not** be used in patients with viral (e.g., **herpes simplex**) or fungal infections, as corticosteroids can exacerbate these conditions. Additionally, it may mask the infection's symptoms. - **Hypersensitivity to Neomycin**: Individuals with a known allergy to **neomycin** or other **aminoglycoside antibiotics** should avoid this medication due to the risk of severe allergic reactions. - **Glaucoma**: Patients with **uncontrolled glaucoma** or those who are at risk of developing glaucoma should not use this medication for extended periods, as **prednisolone acetate** may increase intraocular pressure. - **Cataracts**: Long-term use of corticosteroids like **prednisolone acetate** can promote **cataract formation** and should be avoided in patients with preexisting cataracts or those prone to developing them. - **Pregnancy and Lactation**: **Pregnant women** should only use this combination if absolutely necessary, as corticosteroids can have harmful effects. **Lactating mothers** should avoid direct contact with the eye to prevent the drug from passing into breast milk.

Side Effect

As with any medication, **Prednisolone Acetate + Neomycin Sulphate E&E Prep** may cause some side effects: **Common Side Effects**: - **Eye Irritation**: Mild irritation such as **burning**, **stinging**, or **blurred vision** can occur immediately after application. This typically resolves shortly after the medication is absorbed. - **Redness**: The eye may appear **redder** due to the presence of the medication, especially if used frequently. - **Dryness or Sensitivity**: Temporary **dryness** or **sensitivity to light** can also occur, particularly if the medication is used for prolonged periods. **Serious Side Effects**: - **Glaucoma**: **Prednisolone acetate** can increase **intraocular pressure**, leading to **glaucoma** with long-term use. Patients should monitor for signs like **eye pain** or **blurry vision**. - **Cataract Formation**: Extended use of **steroid medications** like **prednisolone** can contribute to the development of **cataracts**. - **Allergic Reactions**: **Neomycin sulfate** can cause an allergic reaction in some patients, leading to severe symptoms like **itching**, **swelling**, or a **rash** around the eyes or other areas. - **Infection**: Overuse of this combination product may increase the risk of **secondary infections** or worsen existing ones, especially with prolonged steroid use. - **Corneal Thinning or Perforation**: Rarely, corticosteroid use in the eye may lead to **corneal thinning** or **perforation** in patients with pre-existing corneal diseases.

Pregnancy Category ID

17

Mode of Action

**Prednisolone acetate** is a **topical corticosteroid** that works by **reducing inflammation** through the inhibition of several mediators that promote inflammation in the eye. Its mechanism of action includes: - **Immune Suppression**: It suppresses the immune response by reducing the production of **pro-inflammatory cytokines** and other immune system cells responsible for the inflammatory process. - **Vasoconstriction**: It leads to **constriction of blood vessels** and reduces **swelling** by decreasing fluid leakage from blood vessels in the eye. **Neomycin sulfate** is an **antibiotic** that works by inhibiting **bacterial protein synthesis**. It binds to the **30S ribosomal subunit** of bacteria, preventing them from making essential proteins. This disrupts the bacteria's ability to replicate, treating infections caused by susceptible organisms. The combination of **prednisolone acetate** (for inflammation) and **neomycin sulfate** (for bacterial infection) provides a dual therapeutic approach, addressing both the inflammation and the infection simultaneously.

Interaction

While **Prednisolone Acetate + Neomycin Sulphate E&E Prep** has minimal systemic interactions, it is essential to consider potential drug interactions: - **Other Corticosteroids**: The combination of **prednisolone acetate** with other **topical or systemic corticosteroids** can increase the risk of systemic side effects, such as **Cushing's syndrome** or **adrenal suppression**, particularly with prolonged use. - **Aminoglycosides and Other Antibiotics**: When combined with **aminoglycoside antibiotics** (like **gentamicin**), the risk of **nephrotoxicity** or **ototoxicity** may increase. The overall burden on kidney and auditory systems should be considered. - **Ophthalmic Agents**: When used with other **ocular preparations**, the eye drops or ointments should be applied at least **5 minutes apart** to avoid interference with the efficacy of either treatment. - **Vaccines**: **Prednisolone acetate** may suppress immune responses to **live vaccines**, reducing their effectiveness. It is advisable to delay live vaccinations until after the use of the medication is completed.

Pregnancy Category Note

Information not available

Adult Dose

The usual adult dosing for **Prednisolone Acetate + Neomycin Sulphate E&E Prep** is: - **Initial Dose**: Apply 1-2 drops to the affected eye(s) **every 2-4 hours** initially, depending on the severity of the inflammation or infection. - **Maintenance Dose**: Once symptoms improve, the frequency of application may be reduced to **1-2 drops every 4-6 hours**. The dosing schedule may vary depending on the specific condition and how the patient responds to the treatment.

Child Dose

For pediatric patients, **Prednisolone Acetate + Neomycin Sulphate E&E Prep** should be used with caution, and the dosage is typically the same as for adults. However, healthcare providers should adjust the treatment based on the severity of the condition and the child's age or response to therapy. - **Initial Dose**: 1-2 drops to the affected eye(s) every 2-4 hours. - **Maintenance Dose**: Once improvement is seen, reduce to 1-2 drops every 4-6 hours. Children may need more careful monitoring due to the potential for adverse reactions like eye pressure changes or sensitivity to the medication. As always, a **healthcare provider** should be consulted prior to starting treatment to ensure that this medication is suitable for the individual, especially in vulnerable populations like children or patients with other medical conditions.

Renal Dose

Since **Prednisolone Acetate + Neomycin Sulphate E&E Prep** is applied topically to the eyes, there are generally **no renal dose adjustments required**. However, if the patient has **severe renal impairment**, systemic absorption of **neomycin** could potentially increase, and monitoring for any systemic effects or nephrotoxicity may be necessary.

Administration

Information not available

banner

Contact Us / Report Error

Please contact us for any inquiries or report any errors.

Or U can Send Us Email: [email protected]